Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other financing activities (2019 - 2026)

Biodesix filings provide 8 years of Other financing activities readings, the most recent being $28000.0 for Q1 2026.

  • On a quarterly basis, Other financing activities rose 154.55% to $28000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $47000.0, a 27.03% increase, with the full-year FY2025 number at $30000.0, down 31.82% from a year prior.
  • Other financing activities hit $28000.0 in Q1 2026 for Biodesix, down from $585000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $3.6 million in Q4 2022 to a low of -$880000.0 in Q2 2023.
  • Median Other financing activities over the past 5 years was $28000.0 (2026), compared with a mean of $310666.7.
  • Biggest five-year swings in Other financing activities: skyrocketed 9800.0% in 2022 and later crashed 988.89% in 2023.
  • Biodesix's Other financing activities stood at $3.6 million in 2022, then crashed by 74.64% to $912000.0 in 2023, then tumbled by 64.91% to $320000.0 in 2024, then surged by 82.81% to $585000.0 in 2025, then crashed by 95.21% to $28000.0 in 2026.
  • The last three reported values for Other financing activities were $28000.0 (Q1 2026), $585000.0 (Q4 2025), and -$582000.0 (Q3 2025) per Business Quant data.